Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
30.9M
-
Number of holders
-
3
-
Total 13F shares, excl. options
-
525K
-
Shares change
-
-3.24K
-
Total reported value, excl. options
-
$57.4M
-
Value change
-
-$220K
-
Number of buys
-
1
-
Number of sells
-
-2
-
Price
-
$109.51
Significant Holders of CONMED Corp - Common Stock (CNMD) as of Q4 2023
4 filings reported holding CNMD - CONMED Corp - Common Stock as of Q4 2023.
CONMED Corp - Common Stock (CNMD) has 3 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 525K shares
of 30.9M outstanding shares and own 1.7% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.03M shares), VANGUARD GROUP INC (3.42M shares), Capital Research Global Investors (2.76M shares), EARNEST PARTNERS LLC (2.35M shares), STATE STREET CORP (1.19M shares), BANK OF AMERICA CORP /DE/ (992K shares), AMERIPRISE FINANCIAL INC (959K shares), Champlain Investment Partners, LLC (957K shares), LOOMIS SAYLES & CO L P (812K shares), and MACQUARIE GROUP LTD (745K shares).
This table shows the top 3 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.